Home › Funds › KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC › WST

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC reported holding 687,781 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$255.0M, representing 0.95% of its reported portfolio and ranking #31 among its reported holdings. KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)687.78K sh
Reported value held$255.00M
Portfolio Weight0.95%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC's WST position evolved

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC first disclosed a stake in WST in Q3 2023 at 414,675 shares (US$155.6M). The position peaked in Q2 2026 at 760,622 shares, worth US$273.1M. Across 13 filings, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 687,781 shares valued at US$255.0M — a reduction of -72,841 shares quarter over quarter.. Notable position changes include a 58% increase in Q1 2025 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 414.68K $155.59M New
Q4 2023 445.58K $156.90M Add
Q1 2024 555.99K $220.01M Add
Q2 2024 593.69K $195.56M Add
Q3 2024 610.50K $183.25M Add
Q4 2024 632.31K $207.12M Add
Q1 2025 997.88K $223.41M Add
Q2 2025 1.05M $230.03M Add
Q3 2025 1.04M $272.32M Reduce
Q4 2025 955.15K $262.80M Reduce
Q1 2026 858.30K $215.12M Reduce
Q2 2026 760.62K $273.06M Reduce
Q3 2026 687.78K $255.00M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 27 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$744.4M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC held WST?

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC's current position in WST?

As of Q3 2026, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds 687.78K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $255.00M, representing 0.95% of its reported portfolio and ranking #31.

Has KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC been buying or selling WST?

In the latest 13F filing (Q3 2026), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC reduced its position in WST. The position peaked in Q2 2026 at 760.62K shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.